Real-world evidence generation has become central to how life sciences companies approach research, development and commercialization. Yet the data needed to build that evidence is often fragmented, spread across claims, electronic medical records (EMRs), clinical notes, imaging reports and other formats that are not always easy to access or analyze. This fragmentation can limit researchers’ […]